Suppr超能文献

卵巢颗粒细胞瘤的核受体谱分析。

Nuclear receptor profiling of ovarian granulosa cell tumors.

机构信息

Prince Henry's Institute of Medical Research, Institute of Medical Research, Clayton, Victoria 3168, Australia.

出版信息

Horm Cancer. 2011 Jun;2(3):157-69. doi: 10.1007/s12672-011-0069-3.

Abstract

Granulosa cell tumors of the ovary (GCT) represent ~5% of malignant ovarian tumors. The adult form is defined by a mutation in the FOXL2 gene. GCT exhibit many of the features of normal proliferating granulosa cells. We have profiled the expression of the 48 human nuclear receptors (NR) by quantitative RT-PCR in a panel of GCT and in two GCT-derived cell lines, COV434 and KGN. The highest level of expression is seen for COUP-TF2 with abundant expression of PPARγ, SF-1, and TR-α. Estrogen receptor (ER)-β is the most abundant of the steroid receptors with relatively high expression also of AR, ER-α, and PR. The concordance of expression for each NR across the tumors is remarkably high with same discordance between the cell lines and the tumors, particularly the COV434 line. No significant differences were observed with respect to tumor stage for NR expression. These findings provide a full profile of NR expression in GCT which will enable full characterization of their roles and potential as therapeutic targets.

摘要

卵巢颗粒细胞瘤(GCT)占恶性卵巢肿瘤的~5%。成人型由 FOXL2 基因突变定义。GCT 表现出许多正常增殖颗粒细胞的特征。我们通过定量 RT-PCR 在一组 GCT 和两个 GCT 衍生细胞系 COV434 和 KGN 中对 48 个人类核受体(NR)的表达进行了分析。COUP-TF2 的表达水平最高,PPARγ、SF-1 和 TR-α 的表达丰富。雌激素受体(ER)-β 是类固醇受体中最丰富的,AR、ER-α 和 PR 的表达也相对较高。每个 NR 在肿瘤中的表达一致性非常高,细胞系和肿瘤之间的差异也非常大,尤其是 COV434 细胞系。NR 表达与肿瘤分期无显著差异。这些发现提供了 GCT 中 NR 表达的完整图谱,这将能够充分描述它们作为治疗靶点的作用和潜力。

相似文献

1
Nuclear receptor profiling of ovarian granulosa cell tumors.
Horm Cancer. 2011 Jun;2(3):157-69. doi: 10.1007/s12672-011-0069-3.
2
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Mod Pathol. 2010 Nov;23(11):1477-85. doi: 10.1038/modpathol.2010.145. Epub 2010 Aug 6.
3
The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
PLoS One. 2012;7(9):e46270. doi: 10.1371/journal.pone.0046270. Epub 2012 Sep 28.
5
Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
Int J Gynecol Cancer. 2009 Apr;19(3):339-42. doi: 10.1111/IGC.0b013e3181a1cdfd.
7
Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.
Gynecol Oncol. 2008 Jan;108(1):182-90. doi: 10.1016/j.ygyno.2007.09.017. Epub 2007 Oct 29.
8
Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro.
Gynecol Oncol. 2013 Apr;129(1):209-15. doi: 10.1016/j.ygyno.2012.12.034. Epub 2012 Dec 30.
9
Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells.
Mol Endocrinol. 2004 Aug;18(8):1919-28. doi: 10.1210/me.2004-0021. Epub 2004 May 20.
10
Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Int J Biochem Cell Biol. 2016 Mar;72:51-54. doi: 10.1016/j.biocel.2016.01.003. Epub 2016 Jan 11.

引用本文的文献

1
Significance of androgen receptor and its potential for anti-androgen/androgen receptor-antagonist therapy in ovarian cancers.
PLoS One. 2025 May 20;20(5):e0322744. doi: 10.1371/journal.pone.0322744. eCollection 2025.
4
PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer.
Open Life Sci. 2024 Oct 26;19(1):20220982. doi: 10.1515/biol-2022-0982. eCollection 2024.
5
ERβ in Granulosa Cell Tumors and Its Clinical Potential.
Endocrinology. 2023 Apr 17;164(6). doi: 10.1210/endocr/bqad063.
6
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.
Curr Oncol Rep. 2022 Jul;24(7):889-904. doi: 10.1007/s11912-021-01163-2. Epub 2022 Mar 26.
8
Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors.
J Endocr Soc. 2020 Mar 16;4(4):bvaa034. doi: 10.1210/jendso/bvaa034. eCollection 2020 Apr 1.
9
Comparative Tumorigenicity and DNA Damage Induced by Dibenzo[ def,p]chrysene and Its Metabolites in the Mouse Ovary.
Chem Res Toxicol. 2018 Nov 19;31(11):1111-1118. doi: 10.1021/acs.chemrestox.8b00152. Epub 2018 Oct 12.
10
FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells.
Endocrinology. 2018 Apr 1;159(4):1690-1703. doi: 10.1210/en.2017-03207.

本文引用的文献

1
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Mod Pathol. 2010 Nov;23(11):1477-85. doi: 10.1038/modpathol.2010.145. Epub 2010 Aug 6.
2
GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis.
Endocr Relat Cancer. 2010 Jul 28;17(3):709-17. doi: 10.1677/ERC-10-0041. Print 2010 Sep.
3
Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function.
Mol Endocrinol. 2010 Jul;24(7):1393-403. doi: 10.1210/me.2010-0006. Epub 2010 May 25.
4
7
PPAR-gamma coactivator-1alpha regulates progesterone production in ovarian granulosa cells with SF-1 and LRH-1.
Mol Endocrinol. 2010 Mar;24(3):485-96. doi: 10.1210/me.2009-0352. Epub 2010 Feb 4.
9
The importance of ERbeta signalling in the ovary.
J Endocrinol. 2010 Apr;205(1):15-23. doi: 10.1677/JOE-09-0379. Epub 2009 Dec 17.
10
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
PLoS One. 2009 Nov 24;4(11):e7988. doi: 10.1371/journal.pone.0007988.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验